Evidence map›Paper›PMID 34784870›Full record

ArticleCurrent neuropharmacology2022

Perspective on the Relationship between GABAA Receptor Activity and the Apparent Potency of an Inhibitor.

Allison L Germann, Spencer R Pierce, Alex S Evers, Joe Henry Steinbach, Gustav Akk

Open access · greenAbstract read
In one paragraph

Article in Current neuropharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Potentiation of the GABABiophysical journal · 2024
    Article
  4. Article
  5. Extra-Synaptic GABABiomolecules · 2023
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Allison L GermannDepartment of Anesthesiology (ALG, SRP, ASE, JHS, GA), Washington University School of Medicine, St. Louis, MO 63110,United States.
Spencer R PierceDepartment of Anesthesiology (ALG, SRP, ASE, JHS, GA), Washington University School of Medicine, St. Louis, MO 63110,United States.
Alex S EversDepartment of Anesthesiology (ALG, SRP, ASE, JHS, GA), Washington University School of Medicine, St. Louis, MO 63110,United States | The Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO 63110, USA.
Joe Henry SteinbachDepartment of Anesthesiology (ALG, SRP, ASE, JHS, GA), Washington University School of Medicine, St. Louis, MO 63110,United States | The Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO 63110, USA.
Gustav AkkDepartment of Anesthesiology (ALG, SRP, ASE, JHS, GA), Washington University School of Medicine, St. Louis, MO 63110,United States | The Taylor Family Institute for Innovative Psychiatric Research, Washington University School of Medicine, St. Louis, MO 63110, USA.
Taylor Family Institute for Innovative Psychiatric ResearchWashington University in St. Louis · US

Funding

MOLECULAR SITES OF NEUROSTEROID BINDINGR01GM108799 · NIGMS · WASHINGTON UNIVERSITY · PI EVERS, ALEX S. · 2014 to 2022
$4.0M
SYNERGISTIC ACTIONS OF INTRAVENOUS ANESTHETICSR01GM108580 · NIGMS · WASHINGTON UNIVERSITY · PI AKK, GUSTAV · 2014 to 2021
$2.4M
GABAA receptors: function, physiology and involvement in anesthesiaR35GM140947 · NIGMS · WASHINGTON UNIVERSITY · PI AKK, GUSTAV · 2021 to 2025
$1.8M
National Institutes of Health National Institute of General Medical Sciences R01GM108580, R35GM140947, R01GM108799NIGMS NIH HHS R01 GM108580NIGMS NIH HHS R01 GM108799NIGMS NIH HHS R35 GM140947
6 · The paper itself

Abstract

backgroundIn electrophysiological experiments, inhibition of a receptor-channel, such as the GABAA receptor, is measured by co-applying an agonist producing a predefined control response with an inhibitor to calculate the fraction of the control response remaining in the presence of the inhibitor. The properties of the inhibitor are determined by fitting the inhibition concentration- response relationship to the Hill equation to estimate the midpoint (IC50) of the inhibition curve Objective: We sought to estimate sensitivity of the fitted IC50 to the level of activity of the control response Methods: The inhibition concentration-response relationships were calculated for models with distinct mechanisms of inhibition. In Model I, the inhibitor acts allosterically to stabilize the resting state of the receptor. In Model II, the inhibitor competes with the agonist for a shared binding site. In Model III, the inhibitor stabilizes the desensitized state.

resultsThe simulations indicate that the fitted IC50 of the inhibition curve is sensitive to the degree of activity of the control response. In Models I and II, the IC50 of inhibition was increased as the probability of being in the active state (PA) of the control response increased. In Model III, the IC50 of inhibition was reduced at higher PA.

conclusionWe infer that the apparent potency of an inhibitor depends on the PA of the control response. While the calculations were carried out using the activation and inhibition properties that are representative of the GABAA receptor, the principles and conclusions apply to a wide variety of receptor- channels.

Indexed as

Receptors, GABA-ABinding SitesHumansReceptors, GABA-AactivationGABAA receptorIC50inhibitionmodeling

Identifiers

PMID34784870
PMCPMC9199547
OpenAlexW3213720700

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.